DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs

Morning Consult published an opinion piece by NACDS President and CEO Steve Anderson last week entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.” The op-ed emphasizes the threat of DIR (direct and indirect remuneration) fees and lays out the ways in which DIR fee reform will lower patients’ out-of-pocket costs and reduce overall healthcare costs.

As Anderson states in summary, “it is simply unsustainable for pharmacies – or for any business – to be undercompensated, often below cost, for goods and services, and for this reimbursement to be completely unpredictable. That is just the beginning of the story, as the unsustainable cycle proceeds from there: higher drug costs, lower medication adherence, diminished patient health, greater reliance on expensive treatments, higher overall healthcare costs.”

Read More

Leave a Reply